Journal of the National Comprehensive Cancer Network : JNCCN
-
J Natl Compr Canc Netw · Jan 2014
Case ReportsBrentuximab vedotin in patients with relapsed HIV-related lymphoma.
Lymphoma is a well-recognized complication in patients infected with HIV. Although its incidence has declined since the advent of antiretroviral therapy, it remains higher than seen in the general population. ⋯ In patients who experience relapse, however, fewer data are available on the role of immunotherapy and its impact on outcomes. This case report presents 2 patients with relapsed HIV-associated lymphoma who experienced a second complete remission after treatment with the immunotherapy agent brentuximab vedotin.